ArticleFrontiers in pharmacology2021

Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives.

Bashir Lawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.